(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide

C50H81N3O13 — CID 59780225

IUPAC(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C(=O)NC(C)c2cccc3ccccc23)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C50H81N3O13/c1-15-38-50(11,60)42(55)32(7)53(47(58)51-31(6)35-22-18-20-34-19-16-17-21-36(34)35)26-27(2)24-48(9,59)44(66-46-40(54)37(52(12)13)23-28(3)62-46)29(4)41(30(5)45(57)64-38)65-39-25-49(10,61-14)43(56)33(8)63-39/h16-22,27-33,37-44,46,54-56,59-60H,15,23-26H2,1-14H3,(H,51,58)/t27-,28-,29+,30-,31?,32-,33+,37+,38-,39+,40-,41+,42-,43+,44-,46+,48-,49-,50-/m1/s1
InChIKeyBXOWZNFTRSFUGW-KPGAODFQSA-N
MW932.21 g/mol
LogP4.89
Rot. Bonds9

About (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide

(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide (PubChem CID 59780225) has the molecular formula C50H81N3O13 and a molecular weight of 932.21 g/mol. Its IUPAC name is (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide.

Molecular Properties

Compound Name(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide
PubChem CID59780225
Molecular FormulaC50H81N3O13
Molecular Weight932.21 g/mol
Exact Mass931.58
IUPAC Name(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C(=O)NC(C)c2cccc3ccccc23)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C50H81N3O13/c1-15-38-50(11,60)42(55)32(7)53(47(58)51-31(6)35-22-18-20-34-19-16-17-21-36(34)35)26-27(2)24-48(9,59)44(66-46-40(54)37(52(12)13)23-28(3)62-46)29(4)41(30(5)45(57)64-38)65-39-25-49(10,61-14)43(56)33(8)63-39/h16-22,27-33,37-44,46,54-56,59-60H,15,23-26H2,1-14H3,(H,51,58)/t27-,28-,29+,30-,31?,32-,33+,37+,38-,39+,40-,41+,42-,43+,44-,46+,48-,49-,50-/m1/s1
InChIKeyBXOWZNFTRSFUGW-KPGAODFQSA-N
XLogP4.89
TPSA209.18 Ų
H-Bond Donors6
H-Bond Acceptors14
Rotatable Bonds9
Heavy Atoms66
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500932.21
LogP ≤ 54.89
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1014

Analyze (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide?
The IUPAC name of (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide (CID 59780225) is (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide.
What is the SMILES notation for (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide?
The canonical SMILES for (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide is CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C(=O)NC(C)c2cccc3ccccc23)[C@H](C)[C@@H](O)[C@]1(C)O.
What is the InChIKey of (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide?
The InChIKey is BXOWZNFTRSFUGW-KPGAODFQSA-N. The full InChI is InChI=1S/C50H81N3O13/c1-15-38-50(11,60)42(55)32(7)53(47(58)51-31(6)35-22-18-20-34-19-16-17-21-36(34)35)26-27(2)24-48(9,59)44(66-46-40(54)37(52(12)13)23-28(3)62-46)29(4)41(30(5)45(57)64-38)65-39-25-49(10,61-14)43(56)33(8)63-39/h16-22,27-33,37-44,46,54-56,59-60H,15,23-26H2,1-14H3,(H,51,58)/t27-,28-,29+,30-,31?,32-,33+,37+,38-,39+,40-,41+,42-,43+,44-,46+,48-,49-,50-/m1/s1.
What are the key properties of (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide?
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide has a molecular weight of 932.21 g/mol, XLogP of 4.89, 9 rotatable bonds, 6 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-N-(1-naphthalen-1-ylethyl)-15-oxo-1-oxa-6-azacyclopentadecane-6-carboxamide is sourced from PubChem (CID 59780225), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).